Search Results - "González‐San Miguel, J."

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99) : benefit of an early intervention by ESTEVE, J, ESCODA, L, TOMAS, J. F, TORMO, M, SAYAS, M. J, SANCHEZ GODOY, P, COLOMER, D, BOLUFER, P, SANZ, M. A, MARTIN, G, RUBIO, V, DIAZ-MEDIAVILLA, J, GONZALEZ, M, RIVAS, C, ALVAREZ, C, GONZALEZ SAN MIGUEL, J. D, BRUNET, S

“…To determine prognosis of acute promyelocytic leukemia (APL) failing to front-line therapy with all-trans retinoic acid (ATRA) and anthracyclines, outcome of…”
Get full text

Alkaline-Tolerant Bacillus cereus 12GS: A Promising Polyhydroxybutyrate (PHB) Producer Isolated from the North of Mexico by San Miguel-González, Gustavo de J, Alemán-Huerta, María E, Martínez-Herrera, Raul E, Quintero-Zapata, Isela, de la Torre-Zavala, Susana, Avilés-Arnaut, Hamlet, Gandarilla-Pacheco, Fátima L, de Luna-Santillana, Erick de J

“…Environmental pollution caused by petroleum-derived plastics continues to increase annually. Consequently, current research is interested in the search for…”
Get full text

Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia by Sanz, M A, Martin, G, Rayón, C, Debén, G, Tormo, M, Díaz-Mediavilla, J, Esteve, J, González-San Miguel, J D

Get full text

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA group by González, M., Barragán, E., Bolufer, P., Chillón, C., Colomer, D., Borstein, R., Calasanz, M. J., Gómez‐Casares, M. T., Villegas, A., Marugán, I., Román, J., Martín, G., Rayón, C., Debén, G., Tormo, M., Díaz‐Mediavilla, J., Esteve, J., González‐San Miguel, J., Rivas, C., Pérez‐Equiza, K., García‐Sanz, R., Capote, F. J., Ribera, J. M., Arias, J., León, A., Sanz, M. A.

“…Of 167 newly diagnosed acute promyelocytic leukaemia patients, 83 patients were long (L)‐form (50%), eight variable (V)‐form (5%) and 76 short (S)‐form (45%)…”
Get full text

Response to Lengfelder et al by Sanz, MA, Martin, G, Rayón, C, Debén, G, Tormo, M, Díaz-Mediavilla, J, Esteve, J, González-San Miguel, JD

Get full text

Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA by HERNANDEZ, Jesus Maria, MARTIN, Guillermo, DIAZ-MEDIAVILLA, Joaquin, GONZALEZ, Marcos, GONZALEZ-SAN MIGUEL, José David, PEREZ-EQUIZA, Katy, RIVAS, Concha, ESTEVE, Jordi, DEL CARMEN ALVAREZ, Maria, ODRIOZOLA, Jesus, RIBERA, José Maria, SANZ, Miguel Angel, GUTIERREZ, Norma Carmen, CERVERA, José, FERRO, Maria Teresa, CALASANZ, Maria José, MARTINEZ-CLIMENT, José Angel, LUNO, Elisa, TORMO, Mar, RAYON, Consuelo

Get full text

Multiparametric analysis of apoptotic and multidrug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia by SUAREZ, Lilia, VIDRIALES, Ma. Belén, ORFAO, Alberto, SAN MIGUEL, Jesus F, GARCIA-LARANA, José, LOPEZ, Antonio, MARTINEZ, Rafael, MARTIN-REINA, Vicencia, TORMO, Mar, GONZALEZ-SAN MIGUEL, José D, LAVILLA, Esperanza, GARCIA-BOYERO, Raimundo

Get full text

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses by PENARRUBIA, M. J, ODRIOZOLA, J, FERRER, S, STEEGMANNSPANISH, J. L, GONZALEZ, C, MASSAGUE, I, MIGUEL, A, GONZALEZ SAN MIGUEL, J. D, PEREZ ENCINAS, M, LAVILLA, E, GIRALDO, M. P, CASADO, L. F

“…Interferon-alpha (IFN-alpha) is a therapy of unquestionable efficacy in chronic myeloid leukemia (CML) patients. The best dose of IFN-alpha in the treatment of…”
Get full text

Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia by Suarez, L, Vidriales, B, Garcia-Larana, J, Lopez, A, Martinez, R, Martin-Reina, V, Tormo, M, Gonzalez-San Miguel, JD, Lavilla, E, Garcia-Boyero, R, Orfao, A, San Miguel, JF, PETHEMA Cooperative Group

“…Department of Hematology, University Hospital of Salamanca, Paseo de San Vicente 58-182, 37007 Salamanca, Spain. BACKGROUND AND OBJECTIVES: Acute myeloid…”
Get full text

Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features by Baro, J, Richard, C, Calavia, J, González-San Miguel, J D, Bello-Fernández, C, Alsar, M J, Gómez-Casares, M T, Iriondo, A, Conde, E, Hermosa, V

“…Theoretical considerations and preliminary results of clinical trials support the earlier use of autologous bone marrow transplantation (ABMT) in poor…”
Get more information

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome by KRÖGER, N, BRAND, R, VAN BIEZEN, A, CAHN, J.-Y, SLAVIN, S, BLAISE, D, SIERRA, J, ZANDER, A, NIEDERWIESER, D, DE WITTE, T

“…We report the results of 65 patients with treatment-related myelodysplastic syndrome (MDS)/acute myelogenous leukemia (AML) who were transplanted from an…”
Get full text

Alkaline-Tolerant IBacillus cereus/I 12GS: A Promising Polyhydroxybutyrate Producer Isolated from the North of Mexico by San Miguel-González, Gustavo de J, Alemán-Huerta, María E, Martínez-Herrera, Raul E, Quintero-Zapata, Isela, de la Torre-Zavala, Susana, Avilés-Arnaut, Hamlet, Gandarilla-Pacheco, Fátima L, de Luna-Santillana, Erick de J

“…Environmental pollution caused by petroleum-derived plastics continues to increase annually. Consequently, current research is interested in the search for…”
Get full text

Complete splenic embolization in the treatment of immune thrombocytopenic purpura by Martinez Lagares, F, Fernandez Fuertes, F, Hernandez Cabrero, T, Bosch Benitez, J, Gonzalez San Miguel, J, Martín, Y, Tapia Martín, M, Muñíz Montero, F, Viejo Llorente, A, Givica Perez, A, Díaz Cremades, J M

Get full text

Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA by Hernandez, JM, Martin, G, Gutierrez, NC, Cervera, J, Ferro, MT, Calasanz, MJ, Martinez-Climent, JA, Luno, E, Tormo, M, Rayon, C, Diaz-Mediavilla, J, Gonzalez, M, Gonzalez-San Miguel, JD, Perez-Equiza, K, Rivas, C, Esteve, J, Alvarez Mdel, C, Odriozola, J, Ribera, JM, Sanz, MA, PETHA Cooperative Group, Spain

“…Servicio de Hematologia, Hospital Universitario de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain. jmhernandezr@aehh.org BACKGROUND AND…”
Get full text

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients by Lahuerta, Juan José, Martinez‐Lopez, Joaquín, Serna, Javier de la, Bladé, Joan, Grande, Carlos, Alegre, Adrián, Vazquez, Lourdes, García‐Laraña, José, Sureda, Ana, Rubia, Javier de la, Conde, Eulogio, Martinez, Rafael, Perez‐Equiza, Katy, Moraleda, José M., León, Angel, Besalduch, Juan, Cabrera, Rafael, Miguel, José D. Gonzalez‐San, Morales, Alfonso, García‐Ruíz, Juan C., Diaz‐Mediavilla, Joaquín, San‐Miguel, Jesús

“…We have retrospectively analysed 344 multiple myeloma (MM) patients (202 de novo patients) treated in a non‐uniform way in whom high‐dose therapy and…”
Get full text

Tandem transplants with different high‐dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial by Lahuerta, Juan José, Grande, Carlos, Martínez‐Lopez, Joaquín, De La Serna, Javier, Toscano, Rosa, Ortiz, María Cruz, Larregla, Santiago, Conde, Eulogio, Insunza, Andrés, Gonzalez‐San Miguel, José David, Bargay, Juan, Cabrera, Rafael, García‐Ruiz, Juan Carlos, Albó, Carmen, García‐Alonso, Luis, Solano, Fernando, Vivancos, Pilar, León, Angel, San Miguel, Jesús

“…Between 1994 and 1999, 88 multiple myeloma (MM) patients were included in a phase II study to evaluate a tandem autologous stem cell transplantation (ASCT)…”
Get full text